BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,267 | +68.0% | 48,046 | +9.6% | 0.00% | +100.0% |
Q2 2023 | $754 | -18.2% | 43,849 | -21.2% | 0.00% | 0.0% |
Q1 2023 | $922 | +67.3% | 55,612 | -23.1% | 0.00% | 0.0% |
Q4 2022 | $551 | -99.9% | 72,286 | -0.0% | 0.00% | 0.0% |
Q3 2022 | $719,000 | +9.6% | 72,312 | +0.1% | 0.00% | 0.0% |
Q2 2022 | $656,000 | -10.6% | 72,215 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $734,000 | -75.8% | 72,299 | -60.2% | 0.00% | -66.7% |
Q4 2021 | $3,030,000 | -60.4% | 181,647 | +11.2% | 0.00% | -62.5% |
Q3 2021 | $7,656,000 | -57.6% | 163,352 | -44.8% | 0.01% | -57.9% |
Q2 2021 | $18,049,000 | +4.6% | 296,079 | +5.7% | 0.02% | 0.0% |
Q1 2021 | $17,263,000 | +20.4% | 280,245 | +38.9% | 0.02% | +18.8% |
Q4 2020 | $14,342,000 | +382.2% | 201,689 | +154.5% | 0.02% | +300.0% |
Q3 2020 | $2,974,000 | +15.0% | 79,256 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $2,585,000 | +57.0% | 79,256 | +39.5% | 0.00% | +50.0% |
Q1 2020 | $1,647,000 | +135.0% | 56,800 | +184.0% | 0.00% | +100.0% |
Q4 2019 | $701,000 | +84.5% | 20,000 | +13.0% | 0.00% | – |
Q3 2019 | $380,000 | – | 17,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |